Dr Jeffrey Kroon, Amsterdam UMC, The Netherlands, describes the characteristics of the distinct Lp(a) lipidome associated with elevated Lp(a) levels, its impact on pro-inflammatory pathways, and its potential for driving plaque instability and cardiovascular events.
Educational Partners and Supporters
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.